X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-91.62M
↓ 37% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-66.71M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-91.62M | +30.2% |
| 2024 | $-131.23M | -35.9% |
| 2023 | $-96.57M | -25.1% |
| 2022 | $-77.20M | -7.9% |
| 2021 | $-71.52M | -18.8% |
| 2020 | $-60.18M | -24.8% |
| 2019 | $-48.23M | -17.8% |
| 2018 | $-40.94M | -46.7% |
| 2017 | $-27.91M | -28.6% |
| 2016 | $-21.71M | - |